Fund Holdings — Opaleye Management Inc.

Total Portfolio Value:
$571.42M
Total Bought:
$69.90M
Total Sold:
$89.69M
Net Transaction:
-$19.79M
Notable People:
James Aaron Silverman
Securities
▲▼
SharesValue
Q3 2024
▲▼
Q4 2024
▲▼
Change
▲▼
Q3 2024
▲▼
Q4 2024
▲▼
Weight (%)
▲▼
Change
▲▼
Harrow, Inc.(HROW)3,990,0003,990,0000$179.39M$133.86M23.43%-$45.53M
TG Therapeutics, Inc.(TGTX)2,280,0002,260,000-20,000$53.33M$68.03M11.90%+$14.70M
Codexis, Inc.(CDXS)8,770,0008,840,000+70,000$27.01M$42.17M7.38%+$15.16M
Eton Pharmaceuticals, Inc.(ETON)2,780,0002,852,070+72,070$16.68M$37.99M6.65%+$21.31M
Ocular Therapeutix, Inc.(OCUL)5,025,0004,342,500-682,500$43.72M$37.08M6.49%-$6.63M
Arvinas, Inc.(ARVN)1,255,0001,625,000+370,000$30.91M$33.64M5.89%+$2.73M
Rhythm Pharmaceuticals, Inc.(RYTM)500,000500,0000$26.20M$27.99M4.90%+$1.79M
Immunome, Inc.(IMNM)1,237,5002,040,000+802,500$18.09M$21.66M3.79%+$3.57M
Liquidia Corporation(LQDA)1,698,1421,698,1420$16.98M$19.97M3.49%+$2.99M
Edgewise Therapeutics, Inc.(EWTX)522,500480,000-42,500$13.95M$12.82M2.24%-$1.13M
Ginkgo Bioworks Holdings, Inc.CL A(DNA)820,2021,200,000+379,798$6.68M$11.78M2.06%+$5.10M
Cargo Therapeutics Inc541,437750,000+208,563$11.83M$10.81M1.89%-$1.02M
Protara Therapeutics, Inc.(TARA)1,681,1541,825,000+143,846$3.08M$9.64M1.69%+$6.56M
Trevi Therapeutics, Inc.(TRVI)2,567,9902,317,500-250,490$8.58M$9.55M1.67%+$971.0K
Jasper Therapeutics, Inc.(JSPR)353,500400,000+46,500$6.65M$8.55M1.50%+$1.90M
Newamsterdam Pharma Company
ORDINARY SHARES
335,000325,000-10,000$5.56M$8.35M1.46%+$2.79M
Acelyrin Inc1,893,6602,235,000+341,340$9.34M$7.17M1.26%-$2.16M
Nurix Therapeutics, Inc.(NRIX)420,000378,500-41,500$9.44M$7.13M1.25%-$2.31M
Xoma Corp Del250,000250,0000$6.62M$6.57M1.15%-$50.0K
Vaxcyte, Inc.(PCVX)85,00075,000-10,000$9.71M$6.14M1.07%-$3.57M
Gossamer Bio, Inc.NOTE 5 000 6 0(GOSS)000$4.19M$6.09M1.07%+$1.90M
Zentalis Pharmaceuticals, Inc.(ZNTL)967,0001,767,500+800,500$3.56M$5.36M0.94%+$1.80M
Biodesix, Inc.(BDSX)3,815,0003,465,000-350,000$6.97M$5.30M0.93%-$1.67M
Karyopharm Therapeutics IncNOTE 3 000 10 1000$3.96M$4.67M0.82%+$708.9K
Nuvalent Inc64,00058,500-5,500$6.55M$4.58M0.80%-$1.97M
Gossamer Bio, Inc.(GOSS)3,665,0104,490,000+824,990$3.71M$4.06M0.71%+$356.0K
Protagonist Therapeutics Inc105,000105,0000$4.72M$4.05M0.71%-$672.0K
Essa Pharma Inc02,209,998+2,209,998$0$3.96M0.69%+$3.96M
AbCellera Biologics Inc.(ABCL)800,000965,000+165,000$2.08M$2.83M0.49%+$747.5K
UroGen Pharma Ltd.(URGN)404,100220,000-184,100$5.13M$2.34M0.41%-$2.79M
Rezolute, Inc.(RZLT)466,563465,000-1,563$2.26M$2.28M0.40%+$15.7K
Immatics N.V.(IMTX)0165,000+165,000$0$1.17M0.21%+$1.17M
iBio, Inc.(IBIO)375,000375,0000$832.5K$918.8K0.16%+$86.3K
Lexeo Therapeutics, Inc.(LXEO)0130,000+130,000$0$855.4K0.15%+$855.4K
REGENXBIO Inc.(RGNX)080,000+80,000$0$618.4K0.11%+$618.4K
Ventyx Biosciences0280,000+280,000$0$613.2K0.11%+$613.2K
PepGen Inc.(PEPG)179,200110,000-69,200$1.53M$416.9K0.07%-$1.12M
Stoke Therapeutics, Inc.(STOK)025,000+25,000$0$275.8K0.05%+$275.8K
Adagio Medical Holdings, Inc.(ADGM)110,571110,5710$285.3K$116.1K0.02%-$169.2K
Aerovate Therapeutics Inc440,0000-440,000$919.6K$0—-$919.6K
Allakos Inc2,407,6000-2,407,600$1.57M$0—-$1.57M
Applied Therapeutics Inc'1,320,0000-1,320,000$11.22M$0—-$11.22M
Catalyst Pharmaceuticals Inc112,5000-112,500$2.24M$0—-$2.24M
Cytokinetics, Incorporated(CYTK)75,3000-75,300$3.98M$0—-$3.98M
Keros Therapeutics, Inc.(KROS)395,2760-395,276$22.95M$0—-$22.95M
Lyell Immunopharma, Inc.(LYEL)1,395,0000-1,395,000$1.93M$0—-$1.93M
Regulus Therapeutics Inc535,0000-535,000$840.0K$0—-$840.0K
Relmada Therapeutics, Inc.(RLMD)480,0000-480,000$1.56M$0—-$1.56M
Revance Therapeutics Inc275,0000-275,000$1.43M$0—-$1.43M
Syros Pharmaceuticals Inc654,9430-654,943$1.41M$0—-$1.41M
Page 1 of 1
Opaleye Management Inc. — 13F Holdings — Q4 2024 | TickerTrail